Literature DB >> 20054047

Clinical practice. Stage IV chronic kidney disease.

Hanna Abboud1, William L Henrich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054047     DOI: 10.1056/NEJMcp0906797

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  43 in total

1.  Complete correction of anemia by erythropoiesis-stimulating agents is associated with insulin resistance in hemodialysis patients.

Authors:  Gianni Biolo; Gianfranco Guarnieri; Rocco Barazzoni; Giovanni Panzetta
Journal:  Clin Exp Med       Date:  2010-11-16       Impact factor: 3.984

Review 2.  Mass spectrometry in chronic kidney disease research.

Authors:  Michael L Merchant
Journal:  Adv Chronic Kidney Dis       Date:  2010-11       Impact factor: 3.620

3.  Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.

Authors:  Min Jun; Jicheng Lv; Vlado Perkovic; Meg J Jardine
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

Review 4.  Arterial stiffness and increased cardiovascular risk in chronic kidney disease.

Authors:  Yuxia Ma; Lin Zhou; Jinghui Dong; Xiaoshen Zhang; Shi Yan
Journal:  Int Urol Nephrol       Date:  2015-05-20       Impact factor: 2.370

5.  Automated clinical reminders for primary care providers in the care of CKD: a small cluster-randomized controlled trial.

Authors:  Khaled Abdel-Kader; Gary S Fischer; Jie Li; Charity G Moore; Rachel Hess; Mark L Unruh
Journal:  Am J Kidney Dis       Date:  2011-10-07       Impact factor: 8.860

Review 6.  Treatment of IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2013-04-02       Impact factor: 28.314

7.  Tumor necrosis factor alpha -238 G/A and -308 G/A polymorphisms and soluble TNF-α levels in chronic kidney disease: correlation with clinical variables.

Authors:  Diana I Vázquez-Huerta; Bertha A Alvarez-Rodríguez; Jorge F Topete-Reyes; José F Muñoz-Valle; Renato Parra-Michel; Francisco Fuentes-Ramírez; María A Salazar-López; Yeminia Valle; Zyanya Reyes-Castillo; A Cruz-González; Lorena M Brennan-Bourdon; Norma Torres-Carrillo
Journal:  Int J Clin Exp Med       Date:  2014-08-15

8.  Tubular Secretion in CKD.

Authors:  Astrid M Suchy-Dicey; Thomas Laha; Andrew Hoofnagle; Rick Newitt; Tammy L Sirich; Timothy W Meyer; Ken E Thummel; N David Yanez; Jonathan Himmelfarb; Noel S Weiss; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2015-11-27       Impact factor: 10.121

9.  Utilization of an EMR-biorepository to identify the genetic predictors of calcineurin-inhibitor toxicity in heart transplant recipients.

Authors:  Matthew Oetjens; William S Bush; Kelly A Birdwell; Holli H Dilks; Erica A Bowton; Joshua C Denny; Russell A Wilke; Dan M Roden; Dana C Crawford
Journal:  Pac Symp Biocomput       Date:  2014

10.  Choosing wisely and beyond: shared decision making and chronic kidney disease.

Authors:  Phillip Tuso
Journal:  Perm J       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.